255 related articles for article (PubMed ID: 11504119)
1. Continuous intravenous infusion of CGS 26303, an endothelin-converting enzyme inhibitor, prevents and reverses cerebral vasospasm after experimental subarachnoid hemorrhage.
Kwan AL; Lin CL; Chang CZ; Wu HJ; Hwong SL; Jeng AY; Lee KS
Neurosurgery; 2001 Aug; 49(2):422-7; discussion 427-9. PubMed ID: 11504119
[TBL] [Abstract][Full Text] [Related]
2. Oral administration of an inhibitor of endothelin-converting enzyme attenuates cerebral vasospasm following experimental subarachnoid haemorrhage in rabbits.
Kwan AL; Lin CL; Chang CZ; Winardi D; Yen CP; Wu SC; Lee KS; Kassell NF; Howng SL; Savage P; Jeng AY
Clin Sci (Lond); 2002 Aug; 103 Suppl 48():414S-417S. PubMed ID: 12193135
[TBL] [Abstract][Full Text] [Related]
3. Attenuation of experimental subarachnoid hemorrhage-induced increases in circulating intercellular adhesion molecule-1 and cerebral vasospasm by the endothelin-converting enzyme inhibitor CGS 26303.
Lin CL; Kwan AL; Dumont AS; Su YF; Kassell NF; Wang CJ; Wu SC; Kuo CL; Huang CS; Jeng AY; Liu CS
J Neurosurg; 2007 Mar; 106(3):442-8. PubMed ID: 17367067
[TBL] [Abstract][Full Text] [Related]
4. Prevention and reversal of cerebral vasospasm by an endothelin-converting enzyme inhibitor, CGS 26303, in an experimental model of subarachnoid hemorrhage.
Kwan AL; Bavbek M; Jeng AY; Maniara W; Toyoda T; Lappe RW; Kassell NF; Lee KS
J Neurosurg; 1997 Aug; 87(2):281-6. PubMed ID: 9254094
[TBL] [Abstract][Full Text] [Related]
5. Attenuation of experimental subarachnoid hemorrhage-induced cerebral vasospasm by CGS 26303, an endothelin-converting enzyme inhibitor.
Kwan AL; Bavbek M; Jeng AY; Toyoda T; Kassell NF; Lee KS
J Cardiovasc Pharmacol; 1998; 31 Suppl 1():S320-2. PubMed ID: 9595470
[TBL] [Abstract][Full Text] [Related]
6. Prevention and reversal of vasospasm and ultrastructural changes in basilar artery by continuous infusion of CGS 35066 following subarachnoid hemorrhage.
Kwan AL; Lin CL; Yen CP; Winardi W; Su YF; Winardi D; Dai ZK; Jeng AY; Kassell NF; Howng SL; Wang CJ
Exp Biol Med (Maywood); 2006 Jun; 231(6):1069-74. PubMed ID: 16741051
[TBL] [Abstract][Full Text] [Related]
7. Attenuation of SAH-induced cerebral vasospasm by a selective ECE inhibitor.
Kwan AL; Lin CL; Chang CZ; Wu SC; Howng SL; Jeng AY
Neuroreport; 2002 Feb; 13(2):197-9. PubMed ID: 11893909
[TBL] [Abstract][Full Text] [Related]
8. Systemic administration of an inhibitor of endothelin-converting enzyme for attenuation of cerebral vasospasm following experimental subarachnoid hemorrhage.
Caner HH; Kwan AL; Arthur A; Jeng AY; Lappe RW; Kassell NF; Lee KS
J Neurosurg; 1996 Nov; 85(5):917-22. PubMed ID: 8893732
[TBL] [Abstract][Full Text] [Related]
9. CGS 26303 upregulates mRNA expression of heme oxygenase-1 in brain tissue of rats subjected to experimental subarachnoid hemorrhage.
Yen CP; Chen SC; Lin TK; Wu SC; Chang CY; Lue SI; Jeng AY; Kassell NF; Kwan AL
J Cardiovasc Pharmacol; 2004 Nov; 44 Suppl 1():S474-8. PubMed ID: 15838352
[TBL] [Abstract][Full Text] [Related]
10. Endothelin-converting enzyme inhibitors for the treatment of subarachnoid hemorrhage-induced vasospasm.
Lin CL; Winardi W; Jeng AY; Kwan AL
Neurol Res; 2006 Oct; 28(7):721-9. PubMed ID: 17164035
[TBL] [Abstract][Full Text] [Related]
11. Attenuation of hemolysate-induced cerebrovascular endothelial cell injury and of production of endothelin-1 and big endothelin-1 by an endothelin-converting enzyme inhibitor.
Chang CZ; Winardi D; Lin CL; Kwan AL; Jeng AY; Kassell NF; Howng SL; Lee KS
Surg Neurol; 2002; 58(3-4):181-7; discussion 187-8. PubMed ID: 12480208
[TBL] [Abstract][Full Text] [Related]
12. [D-Val22]big ET-1[16-38] inhibits endothelin-converting enzyme activity: a promising concept in the prevention of cerebral vasospasm.
Zimmermann M; Jung CS; Vatter H; Raabe A; Seifert V
Neurosurg Rev; 2003 May; 26(2):125-32. PubMed ID: 12962299
[TBL] [Abstract][Full Text] [Related]
13. Alteration of basilar artery rho-kinase and soluble guanylyl cyclase protein expression in a rat model of cerebral vasospasm following subarachnoid hemorrhage.
Wang CJ; Lee PY; Wu BN; Wu SC; Loh JK; Tsai HP; Chung CL; Kassell NF; Kwan AL
Biomed Res Int; 2014; 2014():531508. PubMed ID: 24982890
[TBL] [Abstract][Full Text] [Related]
14. Systemic administration of the endothelin-A receptor antagonist TBC 11251 attenuates cerebral vasospasm after experimental subarachnoid hemorrhage: dose study and review of endothelin-based therapies in the literature on cerebral vasospasm.
Wanebo JE; Arthur AS; Louis HG; West K; Kassell NF; Lee KS; Helm GA
Neurosurgery; 1998 Dec; 43(6):1409-17; discussion 1417-8. PubMed ID: 9848855
[TBL] [Abstract][Full Text] [Related]
15. Prevention of cerebral vasospasm by a capsaicin derivative, glyceryl nonivamide, in an experimental model of subarachnoid hemorrhage.
Lin CL; Lo YC; Chang CZ; Kwan AL; Chen IJ; Howng SL
Surg Neurol; 2001 May; 55(5):297-301. PubMed ID: 11516473
[TBL] [Abstract][Full Text] [Related]
16. Delayed administration of the K+ channel activator cromakalim attenuates cerebral vasospasm after experimental subarachnoid hemorrhage.
Kwan AL; Lin CL; Wu CS; Chen EF; Howng SL; Kassell NF; Lee KS
Acta Neurochir (Wien); 2000; 142(2):193-7. PubMed ID: 10795894
[TBL] [Abstract][Full Text] [Related]
17. Broad-spectrum and selective serine protease inhibitors prevent expression of platelet-derived growth factor-BB and cerebral vasospasm after subarachnoid hemorrhage: vasospasm caused by cisternal injection of recombinant platelet-derived growth factor-BB.
Zhang Z; Nagata I; Kikuchi H; Xue JH; Sakai N; Sakai H; Yanamoto H
Stroke; 2001 Jul; 32(7):1665-72. PubMed ID: 11441217
[TBL] [Abstract][Full Text] [Related]
18. Attenuation of experimental subarachnoid hemorrhage--induced cerebral vasospasm by the adenosine A2A receptor agonist CGS 21680.
Lin CL; Shih HC; Lieu AS; Lee KS; Dumont AS; Kassell NF; Howng SL; Kwan AL
J Neurosurg; 2007 Mar; 106(3):436-41. PubMed ID: 17367066
[TBL] [Abstract][Full Text] [Related]
19. Endothelin and subarachnoid hemorrhage-induced cerebral vasospasm: pathogenesis and treatment.
Lin CL; Jeng AY; Howng SL; Kwan AL
Curr Med Chem; 2004 Jul; 11(13):1779-91. PubMed ID: 15279581
[TBL] [Abstract][Full Text] [Related]
20. Systemic administration of mexiletine for attenuation of cerebral vasospasm following experimental subarachnoid haemorrhage.
Caner H; Kwan AL; Bavbek M; Kilinc K; Durieux M; Lee K; Kassell NF
Acta Neurochir (Wien); 2000; 142(4):455-61. PubMed ID: 10883344
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
